SELTOLZA

Welcome to the Brand page for “SELTOLZA”, which is offered here for Cell therapy pharmaceutical preparations; pharmaceutical immunotherapy preparations for use in cancer treatment; t-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered t-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered t-cell receptors for use in cancer treatment;cell therapy medical treatment services; medical immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered t-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered t-cell receptor and infusion of the transduced white blood cells back into the patient;.

Its status is currently believed to be active. Its class is unavailable. “SELTOLZA” is believed to be currently owned by “Adaptimmune Limited”.

Owner:
ADAPTIMMUNE LIMITED
Owner Details
Description:
Cell therapy pharmaceutical preparations; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment;Cell therapy medical treatment services; medical immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient;
Categories: CELL THERAPY PHARMACEUTICAL PREPARATIONS